It has been found that in a xenograft model, the hemopexin domain of MMP-9 was an inhibiting factor in angiogenesis, as demonstrated by decreased invasion of glioblastoma cells overexpressing the MMP-9 hemopexin domain [26]. This evidence concerns the gene HPX and glioblastoma.